Reprogramming cells with synthetic proteins
Open Access
- 1 January 2015
- journal article
- review article
- Published by Medknow in Asian Journal of Andrology
- Vol. 17 (3) , 394-402
Abstract
Conversion of one cell type into another cell type by forcibly expressing specific cocktails of transcription factors (TFs) has demonstrated that cell fates are not fixed and that cellular differentiation can be a two-way street with many intersections. These experiments also illustrated the sweeping potential of TFs to "read" genetically hardwired regulatory information even in cells where they are not normally expressed and to access and open up tightly packed chromatin to execute gene expression programs. Cellular reprogramming enables the modeling of diseases in a dish, to test the efficacy and toxicity of drugs in patient-derived cells and ultimately, could enable cell-based therapies to cure degenerative diseases. Yet, producing terminally differentiated cells that fully resemble their in vivocounterparts in sufficient quantities is still an unmet clinical need. While efforts are being made to reprogram cells nongenetically by using drug-like molecules, defined TF cocktails still dominate reprogramming protocols. Therefore, the optimization of TFs by protein engineering has emerged as a strategy to enhance reprogramming to produce functional, stable and safe cells for regenerative biomedicine. Engineering approaches focused on Oct4, MyoD, Sox17, Nanog and Mef2c and range from chimeric TFs with added transactivation domains, designer transcription activator-like effectors to activate endogenous TFs to reprogramming TFs with rationally engineered DNA recognition principles. Possibly, applying the complete toolkit of protein design to cellular reprogramming can help to remove the hurdles that, thus far, impeded the clinical use of cells derived from reprogramming technologies.Keywords
This publication has 99 references indexed in Scilit:
- Direct Lineage Conversion of Terminally Differentiated Hepatocytes to Functional NeuronsCell Stem Cell, 2011
- Radical Acceleration of Nuclear Reprogramming by Chromatin Remodeling with the Transactivation Domain of MyoDStem Cells, 2011
- Pluripotency and Cellular Reprogramming: Facts, Hypotheses, Unresolved IssuesCell, 2010
- Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined FactorsCell, 2010
- Directed Evolution of DNA Polymerases for Next‐Generation SequencingAngewandte Chemie International Edition, 2010
- Directed Evolution of an Enhanced and Highly Efficient FokI Cleavage Domain for Zinc Finger NucleasesJournal of Molecular Biology, 2010
- Vitamin C Enhances the Generation of Mouse and Human Induced Pluripotent Stem CellsCell Stem Cell, 2010
- A Small-Molecule Inhibitor of Tgf-β Signaling Replaces Sox2 in Reprogramming by Inducing NanogCell Stem Cell, 2009
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006